Enliven Therapeutics Welcomes Kristine Ball to Board Ahead of Key Phase 3 Trial Launch #USA #Burlingame #Enliven_Therapeutics #relcobatinib #Kristine_Ball

Enliven Therapeutics Welcomes Kristine Ball to Board Ahead of Key Phase 3 Trial Launch #USA #Burlingame #Enliven_Therapeutics #relcobatinib #Kristine_Ball
Enliven Therapeutics Gains FDA Approval for ENABLE-2 Trial of Relcobatinib in CML Patients #United_States #Burlingame #Enliven_Therapeutics #relcobatinib #chronic_myeloid_leukemia